Neurogene Inc. (NGNE)

Neurogene Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	499	46	22	205	591	472
Market Cap Growth	2082.70%	110.02%	-89.40%	-65.38%	25.08%	828.90%
Enterprise Value	345	-136	-56	75	410	330
PE Ratio	5.55	-1.25	-0.39	-3.37	-17.75	-6.80
PB Ratio	2.92	0.25	-0.15	1.43	3.09	3.33
P/FCF Ratio	-10.90	-0.88	-0.39	-4.02	-22.05	-29.02
P/OCF Ratio	-10.90	-0.89	-0.41	-4.30	-24.04	-30.68
EV/EBITDA Ratio	-14.42	4.20	1.08	-1.28	-13.04	-4.79
EV/EBIT Ratio	-12.82	3.74	1.01	-1.24	-12.33	-4.76
EV/FCF Ratio	-8.33	2.63	1.01	-1.48	-15.31	-20.30
Debt / Equity Ratio	0.09	0.09	-0.03	0.09	0.06	0.01
Debt / EBITDA Ratio	-0.45	-0.50	-0.09	-0.22	-0.39	-0.02
Debt / FCF Ratio	-0.26	-0.31	-0.09	-0.26	-0.45	-0.07
Quick Ratio	14.37	8.60	12.33	16.50	24.41	30.17
Current Ratio	14.74	8.72	12.74	16.67	24.66	30.28
Interest Coverage	-2601.27	-3025.42	-27593.50	-	-	-
Return on Equity (ROE)	-30.50%	-34.40%	-106.80%	-37.70%	-20.20%	-78.80%
Return on Assets (ROA)	-26.00%	-28.80%	-42.30%	-33.40%	-18.20%	-75.90%
Return on Capital (ROIC)	-31.76%	-27.48%	40.07%	-38.95%	-16.59%	-49.66%
Earnings Yield	-7.82%	-79.76%	-254.55%	-29.68%	-5.63%	-14.70%
FCF Yield	-12.02%	-113.64%	-253.93%	-24.85%	-4.54%	-3.45%
Buyback Yield / Dilution	-3798.26%	-1080.37%	85.66%	-6.21%	-91.73%	-14.93%
Total Shareholder Return	-3798.26%	-1080.37%	85.66%	-6.21%	-91.73%	-14.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).